Top Doctor in Denver, 5280 Magazine
(2011)
Voted a 5280 best doctor by my peers in response to the question, "Which physician would you trust to treat you and your family?"
Publications
Kelleher C and Linas SL. The patient with hypokalemia or hyperkalemia. In Manual of Nephrology, 6th edition RW Schrier editor, Lippincott,
30. Kelleher CE and Linas SL. Hypertensive Emergencies. Clicnical Critical Care Medicine. Edited by Albert RK, Sluttsky A, Ranieri M, Takala J, Torres A; Mosby Elsevevier
Bristow MR, Linas SL, Port JD. Drugs in the Treatment of Heart Failure Braunwald’s heart disease. Ed by DP Zipes, p Libby, RO Bonow, E Braunwald 7th edition. Elsevier Saunders 569-602 2005
26. Chonchol M and Linas SL. Diagnosis and Management of Ischemic Nephropathy. Clinical J. Am. Society of Nephrology 1 172-181, 2006
. Black HR, Bakris GL, Weber MA, Weiss R, El Shahawy M Marple R, Tannoury MD, Gerber M, Wiens BL, Linas SL, Roden R. Darusentan dose ranging trial for the treatment of resistant hypertension. Submitted
Proctor G, linas SL pseudohypoaldosteronism AJKD in press
76 Hanratty R, Chonchol M, Miriam Dickinson L, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranak EP. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrology Dialysis and Transplantation 25 810-807 2010
Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV, Arterburn S, Sager P and Weber M. Divergent results using clinic and ambulatory blood pressures: Report of a Darusentan-resistant hypertension trial. Hypertension 56, 824-830, 2010.
78 Lesser CS, Lucey CR, Egener B, Braddock CH, Linas SL, Levinson W. A behavioral and Systems View of Professionalism. JAMA 304 2732-2737 2010.
31. Furgeson S.B. and Linas S.L. Mechanism of Type I and Type II Pseudohypoaldosteronism. JASN 21 1842-1845 2010
Moore R. and Linas S.L. Role of Endothelin antagonists in treating hypertension. Current Opinions in Nephrology and Hypertension 19 432-436 2010.